Objectives: To investigate predictors of continence outcomes after robot-assisted radical prostatectomy. Methods: Clinical records of 272 patients who underwent robot-assisted radical prostatectomy were investigated. Preoperative Overactive Bladder Symptom Score, International Prostate Symptom Score and clinicopathological factors were investigated, and relationships between factors and recovery of continence after robot-assisted radical prostatectomy were assessed. The presence of overactive bladder was defined as having urgency for more than once a week and having ≥3 points according to the Overactive Bladder Symptom Score. Results: Age (≤66 years) was significantly associated with continence within 6 months after robot-assisted radical prostatectomy (P = 0.033). The absence of overactive bladder and lower Overactive Bladder Symptom Score (<3) were significantly associated with recovery of continence within 12 months after surgery (both variables P = 0.009). In terms of achieving recovery of continence after robot-assisted radical prostatectomy, Kaplan-Meier curves showed earlier recovery in "age ≤66 years," "prostate weight ≤40 g" and "overactive bladder symptom score <3" (P = 0.0072, 0.0172 and 0.0140, respectively). Multivariate analysis showed that the presence of overactive bladder was an independent negative predictor for recovery of continence within 12 months after surgery (P = 0.019). Conclusions: The presence of baseline overactive bladder seems to represent an independent negative predictor for recovery of continence at 12 months after robotassisted radical prostatectomy.
Introduction
Urinary incontinence is a common postoperative complication that is crucially associated with the quality of life in patients undergoing RARP. In most cases, recovery from urinary incontinence is achieved within 3-6 months. 1 Recently, more data on factors associated with continence after RARP have been documented. Some reports showed that younger age was significantly associated with recovery of continence. [2] [3] [4] [5] Others suggested prostate volume, 3, 6 BMI 3 and preoperative IPSS 2 as most affecting factors. To our knowledge, there has been no literature to explore preoperative OAB diagnosis or OAB symptoms as a possible factor affecting recovery of continence after RARP. In addition, longitudinal assessment of factors associated with recovery of continence is not well known. The objective of the present study was to carry out a longitudinal investigation into the factors associated with recovery of continence after RARP.
questionnaires, such as IPSS and OABSS, were obtained before surgery. Other than the total scores of IPSS, subscores of storage and voiding symptoms of IPSS were also calculated and assessed (IPSS-S and IPSS-V, respectively). OAB was defined as having urgency for more than once a week and also having ≥3 points according to the OABSS, or if the patient was already diagnosed and under OAB medication. 7 Recovery of continence was defined as complete continence (pad-free). Staging was carried out using the American Joint Committee on Cancer TNM staging system. 8 Standard protocol for follow up after discharge was visits at 2 weeks, 1, 3, 6 and 12 months, and a cycle of 6-12 months thereafter. Patients who were followed for at least 3 months were included in the study. Patients were asked to remember the date of achieving continence (padfree), and the data were collected on the next visit. Three patients who had already been treated for OAB before RARP were not included in the OABSS analysis. Patients who requested OAB treatment after RARP were given either antimuscarinics, clenbuterol or mirabegron. Surgeon experience was categorized into the low (≤10 cases) and high (>10 cases) experience group according to our previous study. 9 As one patient died from non-occlusive gastric ischemia 1 month after surgery, a total of 272 patients were evaluated for continence outcomes after RARP.
All the patients provided written informed consent. This study was approved by the institutional review board (#3124), and is in accordance with the Helsinki declaration.
Surgical technique
All patients underwent RARP using the da Vinci surgical robot system (da Vinci-S; Intuitive Surgical Incorporation, Sunnyvale, CA, USA), with the transperitoneal, six-port technique, as described by Menon et al. 10 Bladder neck dissection was carried out without any suspension stitch techniques.
11 Dorsal vein complex was cut by scissors without coagulation, and was vertically running-sutured by 3-0 absorbable monofilament suture. Nerve sparing was carried out in indicated patients. The urethra was cut at the level of the apex of the prostate, so as not to compromise surgical margins. After resection and removal of the prostate, reinforcement of the pelvic floor was carried out using a Rocco's stitch. 12 UV anastomosis was carried out using a 3-0 monocryl running suture advancing in both sides (clockwise and counter clockwise) starting from the 4 to 5 o'clock direction and ending at 11 to 12 o'clock. All patients underwent cystogram on the 6th to 10th postoperative day to check for any urinary leakage. If the surgeon considered that there was no significant leakage, the Foley catheter was removed on postoperative day 5-10. Total n = 272. †OAB was defined as having urgency for at least once a week with a total score of ≥3 points in OABSS. ‡Three patients receiving OAB treatment before RARP, and these data were not included in the analysis regarding OABSS. §Prostate weight refers to the weight of the resected prostate after RARP. ¶Additional treatment includes both adjuvant and salvage therapy started within 1 year.
Statistical analysis

Results
Clinical characteristics of 272 patients who underwent RARP are presented in Table 1 . Median values of patient age and preoperative PSA level were 67 years (IQR 63-70) and 7.7 (IQR 5.6-11.2), respectively. The median values of blood loss, and operative and console time were 300 mL (IQR 120-600), 237 min (IQR 202-279) and 184 min (IQR 153-220), respectively. Data of OABSS results were available in a total of 249 patients. OAB was present in 58 (21%) patients, and 133 patients had OABSS >3 points. There were 16 patients who had additional treatment either by adjuvant or salvage therapy within 1 year after RARP (Table 1) .
Regarding preoperative factors, BMI, diabetes mellitus and IPSS were not associated with recovery of continence. Age ≤66 years and IPSS-S (subscore of storage symptoms) were not statistically significant factors, but tended to be associated with recovery of continence ≤3 months after RARP (P = 0.059 and 0.052, respectively; Table 2 ). Age (≤66 years) was the only significant factor associated with continence ≤6 months after RARP (P = 0.033; Table 2 ). The absence of OAB and lower OABSS (<3) were significantly associated with recovery of continence ≤12 months after surgery (P = 0.009 and 0.008, respectively; Table 2 ). The relationship between comorbidities and continence outcome is shown in Table 3 . Unfortunately, there were no marked findings. The absence of cerebrovascular disease tended to be associated with the recovery of continence ≤12 months (P = 0.096; Table 3 ).
In terms of postoperative factors, the use of OAB treatment was statistically significantly associated with the failure to attain continence at any time-period after surgery (P = 0.004, 0.013 and <0.001 for 3, 6 and 12 months, respectively; Table 4 ). Lower prostate weight (≤40 g) tended to be associated with recovery of continence at 3 months after surgery (P = 0.054; Table 4 ). Surgical factors, such as surgeon experience, console time, time of UV anastomosis, estimated blood loss and nerve sparing, were not associated with continence outcomes.
In multivariate analysis predicting recovery of continence after surgery, lower prostate weight (≤40 g) and the absence of OAB were significant predictors of recovery of continence within 3 and 12 months after RARP (P = 0.045 and 0.019, respectively; Table 5 ).
A total of 31% of patients achieved continence within 3 months, 50% within 6 months and 63% within 12 months after RARP (Fig. 1a) . Patients with younger age (≤66 years), lower prostate weight (≤40 g) and lower OABSS (<3) showed higher rates of continence after RARP (P = 0.0072, 0.0172 and 0.0140, respectively; Fig. 1b-d) .
The rate of pure urgency incontinence increased from 2% and 3% within ≤3 and 6 months to 11% within 12 months after RARP (Fig. 2) .
Discussion
Recovery of continence after RARP depends on multiple factors, such as host-related and surgical factors. In particular, investigating host-related factors is important, as it can easily be assessed preoperatively, and surgeons can provide information to patients before surgery. Host-related and surgical factors associated with recovery of continence include younger age, 2-5 lower BMI, 3 smaller prostate volume, 3, 6 lower preoperative IPSS, 2 length of membranous urethra 13 and nerve preservation. 14, 15 Regarding surgical types, there seems to be no significant difference in continence outcome between the pure laparoscopic and robotic approach in a systematic review carried out by Ficarra et al. 16 In the present study, BMI and nerve preservation were not significant factors of continence.
The present study showed that prostate weight was an independent predictor of continence at 3 months after RARP, which was consistent with the findings reported in previous studies. 3, 6 However, the extent of the size affecting incontinence varies among studies, and there is no unified understanding. For instance, Boczko et al. have shown that patients with prostate size <75 g had a 6-month continence rate of 97%, whereas patients with a larger prostate size had a continence rate of 84%. 6 In a study of the Korean population, patients with prostate volume <40 cc had higher recovery rates of continence compared with patients with larger prostate. 3 In all, prostate weight seems to be relevant to recovery of continence, but the actual size of the prostate that affects the outcome needs to be investigated in future studies. Another finding in the present study was that patients with a younger age had a higher rate of achieving continence after RARP. This finding also reflects previous studies that have shown the influence of age on recovery of continence after RARP. [2] [3] [4] [5] In a study with 452 patients who underwent RARP, younger age (<70 years) was one of the independent predictors of recovery of continence at 3 months after RARP. 3 In another study, with 203 men who underwent RARP, continence rates were lower in men aged ≥70 years when compared with the rates in younger patients at 6 months after RARP, but returned to equivalent levels at 12 months after surgery. 4 Possible reasons for the association between age and recovery of continence can be explained in several ways. First, age is associated with diabetes mellitus and neurological disorders that might influence poor urinary function. 17 Second, increasing age is known to be associated with a decrease of sphincter muscle volume and neural pathway degeneration. 18 The novel finding of the present study was that the "presence of OAB" was a negative independent predictor of continence after RARP. Patients with OAB or patients with higher total scores in the OABSS had worse recovery of continence at 12 months after RARP. These results suggest that the presence of OAB as well as severity of OAB affects recovery of continence after RARP, and that these findings are more prominent in a late stage after surgery. Surprisingly, the "presence of OAB" was not a significant factor until 12 months. Other factors might be stronger than OAB during the early period of the postoperative course. Also, when we focused on the 12-month continence outcome, the rate of urgency continence rose from 3% to 11% for pure urgency incontinence, and 60% to 67% for mixed incontinence (urgency + stress incontinence). Furthermore, patients with OAB might be more vulnerable to incontinence after RARP.
The mechanism of association between OAB and failure to regain continence remains unclear. DO, which is one of the representative urodynamic study findings for OAB, 19 can be observed as a de novo bladder dysfunction in up to 77% of patients after radical prostatectomy. [20] [21] [22] Ficazzola et al. investigated video urodynamics on 60 consecutive men who underwent radical retropubic prostatectomy. 23 They found that although stress incontinence originating from intrinsic deficiency was the main reason for incontinence, urgency incontinence as a result of bladder dysfunction was also noted in 16 of 60 (27%) patients. Another study by Leach et al. concluded that bladder dysfunction might be the cause for incontinence in up to 60% of patients undergoing radical prostatectomy. 24 In addition, DO that could be seen in a common OAB might trigger incontinence after RARP, as urethral closure pressure is known to decline after RARP. 25 In a study by Yanagiuchi et al., the incidence of DO was significantly higher in patients with incontinence at 1 and 3 months after RARP. 26 Although the main reason for post-RARP incontinence is sphincter dysfunction, these findings could suggest that bladder dysfunction might also be associated with post-RARP incontinence. Furthermore, when types of urinary incontinence were investigated in the present study, we found that the rate of urgency incontinence increased to 11% at 12 months.
Cancer-related and surgical factors include clinical T stage, 3 bladder neck preservation, 27 length of membranous urethra 13 and cavernosal nerve preservation. 14, 15 In the present study, nerve preservation was not a significant factor of incontinence. However, most of the nerve preservation was carried out unilaterally (bilateral nerve sparing was performed in three cases). This might have attenuated the influence of nerve preservation on continence outcomes.
The limitation of the present study was that there might be a bias derived from the method of collecting the date of being pad-free after RARP. Patients might declare an inaccurate date of being pad-free, and the declared date might become more inaccurate as the time lapse between the visit and actual date increases.
In conclusion, the presence of preoperative OAB was an independent negative predictor of continence at 12 months after RARP, and both the diagnosis of OAB and severity of OAB were associated with the recovery of continence. However, functional studies using urodynamics are necessary to further elucidate the present findings. Fig. 2 Proportion of types of incontinence after RARP. Proportion of urgency incontinence, stress incontinence and mixed incontinence (urgency + stress incontinence) were investigated for ≤3, ≤6 and ≤12 months after RARP. Proportion of urgency incontinence increased from 2% and 3% at 3 and 6 months to 11% at 12 months.
